Common diabetes pill tested as potential Heart-Saver in major trial
NCT ID NCT07288749
Summary
This study aims to find out if the diabetes medication glimepiride can help people who have both type 2 diabetes and chronic heart failure. It will involve about 1,500 participants who will be randomly assigned to receive either glimepiride or a placebo (a dummy pill) for three years. The main goal is to see if the drug reduces serious heart-related problems like death, heart transplants, or hospital visits for worsening heart failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hostipal
Wuhan, Hubei, 430030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.